Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Luc Richard who wrote (828)	2/8/1998 8:43:00 PM
From: Joyce Majure	Read Replies (1) of 1501

Latest comments from Maedel's (February) is basically a hold--not because of any bad news, but because of the continued delays in clinical testing. In this speculative market, no news is taken as bad news by those who are looking for quick bucks. I too invested in IZP because of its potential and am in for the long haul. It is very tempting to add more at these prices, because the potential for BIG returns is phenomenal. On the other hand, if the clinical testing fails, how much am I willing to throw away? Always the dilemma in biotech. As I see it, if clinical testing comes out positive, there will be time to buy more before ALL the world knows about it. Even if you end up buying more at $5.00/share on good Phase II results, we will stand to make money.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next